BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Drug Development

  MethylGene Reports Preclinical Results Of Its Antifungal Compound MG3290 In Combination With Azoles

  September 29, 2006

   · 

  1 min read
• Drug Development

  Schering-Plough Corporation Release: Efficacy Of Once-Daily AVELOX(R) In Treating Complicated Intra-Abdominal Infections Highlighted In Two Clinical Data Presentations At ICAAC

  September 29, 2006

   · 

  9 min read
• Drug Development

  Advanced Life Sciences Release: Clinical Data On The Antimicrobial Activity Of Cethromycin Presented At The 46th Interscience Conference On Antimicrobial Agents And Chemotherapy

  September 29, 2006

   · 

  5 min read
• Business

  Haemonetics Corporation Sets Date For Q2FY07 Earnings Release And Conference Call -- October 31, 2006

  September 29, 2006

   · 

  1 min read
• Business

  Biota Holdings Limited Welcomes GlaxoSmithKline License Grant For The Manufacture And Supply Of Zanamivir In China And Other Countries

  September 29, 2006

   · 

  2 min read
• EGM Of ICON-PLC Approves Stock Split

  September 29, 2006

   · 

  1 min read
• Business

  Precision Optics Corporation Announces Fourth Quarter And Year End Results

  September 29, 2006

   · 

  3 min read
• Biotech Bay

  Abbott Laboratories To Provide A Free Blood Glucose Monitoring System To All Becton, Dickinson and Company Logic(R) Patients

  September 29, 2006

   · 

  2 min read
• Drug Development

  GlaxoSmithKline And Vertex Pharmaceuticals Incorporated Announce Virologic And Drug Resistance Results From Protease Inhibitor Study

  September 29, 2006

   · 

  8 min read
• Policy

  Merck & Co., Inc. Revises Regulatory Filing Timeline For MK-0524B, An Investigational Fixed-Dose Combination Of MK-0524A And Simvastatin; Kos Pharmaceuticals Shares Rise On Merck Delay

  September 29, 2006

   · 

  3 min read